[1] Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;3(10223):470 − 3. http://dx.doi.org/10.1016/S0140-6736(20)30185-9CrossRef
[2] Tan WJ, Zhao X, Ma XJ, Wang WL, Niu PH, XU WB, et al. Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan, China 2019−2020. China CDC Weekly 2020; 2(4): 61-2. http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c.http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c
[3] Zhu N, Zhang DY, Wang WL, Li XW, Yang B, Song JD, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;3(8):727 − 33. http://dx.doi.org/10.1056/NEJMoa2001017CrossRef
[4] Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;3(10223):15 − 21. http://dx.doi.org/10.1016/s0140-6736(20)30183-5CrossRef
[5] Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;3(4):536 − 44. http://dx.doi.org/10.1038/s41564-020-0695-zCrossRef
[6] Su S, Wong G, Shi WF, Liu J, Lai ACK, Zhou JY, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;3(6):490 − 502. http://dx.doi.org/10.1016/j.tim.2016.03.003CrossRef
[7] Lu RJ, Zhao X, Li J, Niu PH, Yang B, Wu HL, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;3(10224):565 − 74. http://dx.doi.org/10.1016/s0140-6736(20)30251-8CrossRef
[8] Quiñ ones-Mateu ME, Avila S, Reyes-Teran G, Martinez MA, et al. Deep sequencing: becoming a critical tool in clinical virology. J Clin Virol 2014;3(1):9 − 19. http://dx.doi.org/10.1016/j.jcv.2014.06.013CrossRef
[9] Tewhey R, Bansal V, Torkamani A, Topol EJ, Schork NJ, et al. The importance of phase information for human genomics. Nat Rev Genet 2011;3(3):215 − 23. http://dx.doi.org/10.1038/nrg2950CrossRef
[10] Mu WB, Lu HM, Chen J, Li SW, Elliott AM. Sanger confirmation is required to achieve optimal sensitivity and specificity in next-generation sequencing panel testing. J Mol Diagn 2016;3(6):923 − 32. http://dx.doi.org/10.1016/j.jmoldx.2016.07.006CrossRef